跳至主要内容
临床试验/CTRI/2024/01/061897
CTRI/2024/01/061897尚未招募3 期

Intraglandular platelet rich plasma injection in moderate to severe dry eye disease: A placebo-controlled trial - NI

V Prasad Eye Institute0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Aged 18–70 years
  • 2. Have OSDI scores =33 or Oxford staining grade =2
  • 3. Have a best corrected visual acuity (BCVA) in both eyes of +0.7 logMAR
  • 4.Diagnosis of DED in both eyes supported by the criteria mentioned below
  • Defined by at least one eye meeting all the following criteria:
  • o A symptom severity score of =22 for OSDI
  • oAn unanesthetized Schirmer Tear Test (STT) score of =1 mm and =5 mm per 5 minutes
  • oEvidence of ocular surface staining (total fluorescein staining score of at least 3) [0-15 scale])
  • 5. Have normal lid anatomy and no other ocular disease except refractive errors or cataract

排除标准

  • 1. Uncontrolled systemic diseases, active infection or chronic kidney disease, liver cirrhosis, advance cancer.
  • 2. Pregnant or nursing women.
  • 3.Have not recently used the following medications, interventions, surgery, Anticoagulants or anti-platelets,Topical undiluted blood products within 3 months, Punctal plug or contact lenses, Ocular surgery within 6 months.
  • 4.Have no contraindication for blood donation, Positive HIV, hepatitis B or C, or syphilis, Anaemia.Hemoglobin less than 110 grams per Litre.

研究者

发起方
V Prasad Eye Institute

相似试验